 | | PRD_001167 | | Name: | bicyclic peptide UK811 | | Formula: | C74 H119 N26 O22 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001168 | | Name: | bicyclic peptide UK903 | | Formula: | C72 H103 N19 O19 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_000902 | | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H50 N4 O5 | | Description: | vinylketone carmaphycin analogue VNK1, single bound form | | Definition date: | 2014-01-29 | | Last modified: | 2017-05-04 |
|
 | | PRD_000904 | | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H52 N4 O5 | | Description: | vinylketone carmaphycin analogue VNK1, double bound form | | Definition date: | 2014-01-29 | | Last modified: | 2017-05-04 |
|
 | | PRD_000930 | | Name: | N-hexanoyl-L-valyl-N~1~-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H52 N4 O6 | | Description: | epoxyketone carmaphycin analogue 3, bound form | | Definition date: | 2014-01-29 | | Last modified: | 2023-11-03 |
|
 | | PRD_000956 | | Name: | N-[(2S)-1-({(2S)-1-{[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]amino}-4-[(R)-methylsulfinyl]-1-oxobutan-2-yl}amino)-3-methyl-1-oxobutan-2-yl]hexanamide | | Formula: | C25 H49 N3 O6 S | | Description: | Carmaphycin A, bound form | | Definition date: | 2014-01-29 | | Last modified: | 2023-11-03 |
|
 | | PRD_001157 | | Name: | Ser-Leu-Phe-His-Phenylalanyl-reduced-peptide-bond-Tyrosyl-Thr-Pro | | Formula: | C51 H69 N10 O11 | | Definition date: | 2014-01-15 | | Last modified: | 2023-11-03 |
|
 | | PRD_001211 | | Name: | LEDGF peptide | | Formula: | C27 H45 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2014-03-25 |
|
 | | PRD_001212 | | Name: | LEDGF peptide | | Formula: | C28 H48 N9 O10 S2 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001213 | | Name: | PK(NLE)DN(DVA) peptide | | Formula: | C30 H51 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001214 | | Name: | PKIDN(DPR) peptide | | Formula: | C30 H49 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001156 | | Name: | PL-55 | | Formula: | C41 H67 N9 O12 P S | | Definition date: | 2013-12-11 | | Last modified: | 2013-12-11 |
|
 | | PRD_001159 | | Name: | PL-74 | | Formula: | C46 H74 N10 O13 P S | | Definition date: | 2013-12-11 | | Last modified: | 2013-12-11 |
|
 | | PRD_001125 | | Name: | Peptide ligand | | Formula: | C51 H75 N9 O14 | | Definition date: | 2013-12-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_002043 | | Name: | Goblin1 | | Formula: | C34 H60 N8 O12 | | Definition date: | 2013-12-04 | | Last modified: | 2022-10-29 |
|
 | | PRD_001189 | | Name: | ATSP-7041 stapled-peptide | | Formula: | C87 H124 N16 O22 | | Definition date: | 2013-11-20 | | Last modified: | 2023-11-03 |
|
 | | PRD_001130 | | Name: | SmBz, cyclosporin A derivative | | Formula: | C70 H118 N11 O14 | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001186 | | Name: | Myosin-A, stapled peptide | | Formula: | C97 H175 N31 O23 S | | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | | Definition date: | 2013-11-06 | | Last modified: | 2017-12-15 |
|
 | | PRD_001187 | | Name: | pGly[807,811], a stapled myoA tail peptide | | Formula: | C98 H177 N31 O23 S | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001188 | | Name: | hydrogen bond surrogate (HBS) myoA helix mimetic | | Formula: | C92 H167 N29 O22 S | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001173 | | Name: | Phosphothreonine ester-containing peptide | | Formula: | C44 H72 N8 O13 P | | Definition date: | 2013-10-30 | | Last modified: | 2014-01-23 |
|
 | | PRD_000777 | | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | | Formula: | C41 H69 N9 O9 | | Definition date: | 2013-10-30 | | Last modified: | 2013-10-30 |
|
 | | PRD_000778 | | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-3-phenylpropyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | | Formula: | C44 H67 N9 O9 | | Definition date: | 2013-10-30 | | Last modified: | 2013-10-30 |
|
 | | PRD_001174 | | Name: | (2S)-2-{[(2R,5S)-5-{[(2S,3S)-2-{[(2S,3R)-2-(acetylamino)-3-hydroxybutanoyl]amino}-3-methylpentanoyl]amino}-2-butyl-4-oxononanoyl]amino}-N~1~-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]pentanediamide | | Formula: | C36 H66 N10 O9 | | Definition date: | 2013-10-16 | | Last modified: | 2017-09-14 |
|
 | | PRD_001025 | | Name: | Trypsin inhibitor 1 | | Formula: | C67 H107 N18 O19 S2 | | Definition date: | 2013-10-09 | | Last modified: | 2023-11-03 |
|
